Article

Bausch & Lomb launches microsurgical system in Europe

Rochester, NY-Bausch & Lomb introduced its microsurgical system for cataract (Stellaris Vision Enhancement System) in the European market at the annual meeting of the European Society of Cataract and Refractive Surgeons in Stockholm, Sweden.

Rochester, NY-Bausch & Lomb introduced its microsurgical system for cataract (Stellaris Vision Enhancement System) in the European market at the annual meeting of the European Society of Cataract and Refractive Surgeons in Stockholm, Sweden.

The system is appropriate for all techniques, particularly 1.8-mm biaxial and 1.8-mm coaxial procedures, according to the company. Features include fluidics management technology that allows surgeons to choose either a flow-vacuum module or an advanced vacuum module; a six-crystal phaco handpiece designed to be ergonomic; a wireless-enabled, dual-linear foot pedal; and a high-definition touch-screen display.

“The system lets surgeons operate at [their] own pace when using smaller incisions, without compromising speed or efficiency, while delivering excellent optical outcomes. It limits complications, reduces the rehabilitation time for the patient, and provides excellent results directly after surgery,” said H. Burkhard Dick, MD, of the Center for Vision Science at Ruhr University, Bochum, Germany. “After more than 50 cases . . . I continue to be impressed.”

The microsurgical system was launched in the United States market in April at the annual meeting of the American Society of Cataract and Refractive Surgery.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.